Publications - Page 40 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Pneumopathies interstitielles diffuses (PID) 02/08/23
Variability in Global Prevalence of Interstitial Lung Disease

Kaul B, Cottin V, Collard HR, Valenzuela C.

Front Med (Lausanne). 2021 Nov 4;8:751181.
Pneumopathies interstitielles diffuses (PID) 02/08/23
Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis

Nasser M, Si-Mohamed S, Turquier S, Traclet J, Ahmad K, Philit F, Bonniaud P, Chalabreysse L, Thivolet-Béjui F,Cottin V.

Orphanet J Rare Dis. 2021 Oct 9;16(1):419.
Pneumopathies interstitielles diffuses (PID) 02/08/23
Diagnosis yield and safety of surgical biopsy in interstitial lung diseases: a prospective study

Radu D, Freynet O, Kambouchner M, Boubaya M, Nunes H, Uzunhan Y, Brillet PY, Guiraudet P, Noorah MZ, Israël-Biet D, Le Pimpec-Barthes F, Juvin K, Charpentier A, Gibault L, Assouad J, Naccache JM, Antoine M, Tavolaro S, Alifano M, Honoré I, L’Huillier JP, Debrosse D, Dupin C, Pradère P, Debray MP, Cazes A, Mordant P, Castier Y, Beloucif S, Crestani B, Lévy V, Martinod E, Valeyre D.

Ann Thorac Surg. 2021 Sep 29: S0003-4975(21)01672-6. Doi: 10.1016/j.athoracsur.2021.08.056.
Pneumopathies interstitielles diffuses (PID) 02/08/23
Methionine supplementation for multi-organ dysfunction in MetRS-related pulmonary alveolar proteinosis

Hadchouel A, Drummond D, Pontoizeau C, Aoust L, Hurtado Nedelec MM, El Benna J, Gachelin E, Perisson C, Vigier C, Schiff M, Lacaille F, Molina TJ, Berteloot L, Renolleau S, Ottolenghi C, Tréluyer JM, de Blic J, Delacourt C.

Eur Respir J. 2021 Sep 9:2101554. Doi: 10.1183/13993003.01554-2021.
Pneumopathies interstitielles diffuses (PID) 02/08/23
[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach

Tanguy J, Goirand F, Bouchard A, Frenay J, Moreau M, Mothes C, Oudot A, Helbling A, Guillemin M, Bonniaud P, Cochet A, Collin B, Bellaye PS.

Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3058-3074. Doi: 10.1007/s00259-021-05209-2.
Pneumopathies interstitielles diffuses (PID) 02/08/23
A call for evidence in connective tissue diseases-associated interstitial lung disease

Cottin V, Lega JC, Coury F, Nasser M.

Joint Bone Spine. 2021 Sep 15;89(1):105274. Doi: 10.1016/j.jbspin.2021.105274.
Pneumopathies interstitielles diffuses (PID) 02/08/23
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities

Spagnolo P, Ryerson CJ, Putman R, Oldham J, Salisbury M, Sverzellati N, Valenzuela C, Guler S, Jones S, Wijsenbeek M, Cottin V.

Lancet Respir Med. 2021 Sep;9(9):1065-1076. Doi: 10.1016/S2213-2600(21)00017-5.
Pneumopathies interstitielles diffuses (PID) 02/08/23
The progressive fibrotic phenotype in current clinical practice

Wells AU, Brown KK, Cottin V.

Curr Opin Pulm Med. 2021 Sep 1;27(5):368-373. Doi: 10.1097/MCP.0000000000000805.
Pneumopathies interstitielles diffuses (PID) 02/08/23
Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France

Cottin V, Larrieu S, Boussel L, Si-Mohamed S, Bazin F, Marque S, Massol J, Thivolet-Bejui F, Chalabreysse L, Maucort-Boulch D, Jouneau S, Hachulla E, Chollet J, Nasser M.

Front Med (Lausanne). 2021 Aug 30;8:699532. Doi: 10.3389/fmed.2021.699532.
Pneumopathies interstitielles diffuses (PID) 02/08/23
Clinical Impact of Surgical Lung Biopsy for Interstitial Lung Disease in a Reference Center

Le Guen P, Iquille J, Debray MP, Guyard A, Roussel A, Borie R, Dombret MC, Dupin C, Ghanem M, Taille C, Khalil A, Castier Y, Cazes A, Crestani B, Mordant P.

Ann Thorac Surg. 2021 Aug 14: S0003-4975(21)01428-4. Doi: 10.1016/j.athoracsur.2021.07.038.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Variability in Global Prevalence of Interstitial Lung Disease

Nintedanib in idiopathic and secondary pleuroparenchymal fibroelastosis

Diagnosis yield and safety of surgical biopsy in interstitial lung diseases: a prospective study

Methionine supplementation for multi-organ dysfunction in MetRS-related pulmonary alveolar proteinosis

[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach

A call for evidence in connective tissue diseases-associated interstitial lung disease

Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities

The progressive fibrotic phenotype in current clinical practice

Epidemiology, Mortality and Healthcare Resource Utilization Associated With Systemic Sclerosis-Associated Interstitial Lung Disease in France

Clinical Impact of Surgical Lung Biopsy for Interstitial Lung Disease in a Reference Center